The University of Chicago Header Logo

Connection

Nancy Jean Cox to Influenza A Virus, H3N2 Subtype

Back to Details
This is a "connection" page, showing publications Nancy Jean Cox has written about Influenza A Virus, H3N2 Subtype.
Nancy Jean Cox
Connection Strength
2.130
Influenza A Virus, H3N2 Subtype
  1. Improving the selection and development of influenza vaccine viruses - Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015. Vaccine. 2017 02 22; 35(8):1104-1109.
    View in: PubMed
    Score: 0.133
  2. Selection of antigenically advanced variants of seasonal influenza viruses. Nat Microbiol. 2016 05 23; 1(6):16058.
    View in: PubMed
    Score: 0.127
  3. Nonimmunoselected intrastrain genetic variation detected in pairs of high-yielding influenza A (H3N2) vaccine and parental viruses. J Infect Dis. 1994 Dec; 170(6):1432-8.
    View in: PubMed
    Score: 0.115
  4. WHO recommendations for the viruses used in the 2013-2014 Northern Hemisphere influenza vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from October 2012 to January 2013. Vaccine. 2014 Aug 20; 32(37):4713-25.
    View in: PubMed
    Score: 0.109
  5. Update: influenza activity - United States, September 29, 2013-February 8, 2014. MMWR Morb Mortal Wkly Rep. 2014 Feb 21; 63(7):148-54.
    View in: PubMed
    Score: 0.109
  6. Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses. J Gen Virol. 1993 Nov; 74 ( Pt 11):2513-8.
    View in: PubMed
    Score: 0.106
  7. Outbreak of variant influenza A(H3N2) virus in the United States. Clin Infect Dis. 2013 Dec; 57(12):1703-12.
    View in: PubMed
    Score: 0.106
  8. Influenza A virus haemagglutinin polymorphism: pleiotropic antigenic variants of A/Shanghai/11/87 (H3N2) virus selected as high yield reassortants. J Gen Virol. 1993 Jul; 74 ( Pt 7):1311-6.
    View in: PubMed
    Score: 0.104
  9. Human infections with influenza A(H3N2) variant virus in the United States, 2011-2012. Clin Infect Dis. 2013 Jul; 57 Suppl 1:S4-S11.
    View in: PubMed
    Score: 0.104
  10. WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011. Vaccine. 2012 Oct 05; 30(45):6461-71.
    View in: PubMed
    Score: 0.098
  11. Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets. Proc Natl Acad Sci U S A. 2012 Mar 06; 109(10):3944-9.
    View in: PubMed
    Score: 0.095
  12. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep. 2010 Aug 06; 59(RR-8):1-62.
    View in: PubMed
    Score: 0.085
  13. Receptor specificity of influenza A H3N2 viruses isolated in mammalian cells and embryonated chicken eggs. J Virol. 2010 Aug; 84(16):8287-99.
    View in: PubMed
    Score: 0.084
  14. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog. 2008 May 23; 4(5):e1000072.
    View in: PubMed
    Score: 0.073
  15. The global circulation of seasonal influenza A (H3N2) viruses. Science. 2008 Apr 18; 320(5874):340-6.
    View in: PubMed
    Score: 0.072
  16. Adamantane-resistant influenza infection during the 2004-05 season. Emerg Infect Dis. 2008 Jan; 14(1):173-6.
    View in: PubMed
    Score: 0.071
  17. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis. 2007 Jul 15; 196(2):249-57.
    View in: PubMed
    Score: 0.068
  18. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet. 2005 Oct 01; 366(9492):1175-81.
    View in: PubMed
    Score: 0.061
  19. Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957-1972: evidence for genetic divergence and multiple reassortment events. Virology. 2004 Oct 10; 328(1):101-19.
    View in: PubMed
    Score: 0.057
  20. Molecular epidemiology of influenza A(H3N2) virus reinfections. J Infect Dis. 2002 Apr 01; 185(7):980-5.
    View in: PubMed
    Score: 0.047
  21. Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol. 2001 Jun; 82(Pt 6):1397-1406.
    View in: PubMed
    Score: 0.045
  22. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60. Virology. 1979 Aug; 97(1):190-4.
    View in: PubMed
    Score: 0.040
  23. Genetic variation in neuraminidase genes of influenza A (H3N2) viruses. Virology. 1996 Oct 01; 224(1):175-83.
    View in: PubMed
    Score: 0.033
  24. Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. MMWR Morb Mortal Wkly Rep. 2014 Jun 06; 63(22):483-90.
    View in: PubMed
    Score: 0.028
  25. Quantification of immunoreactive viral influenza proteins by immunoaffinity capture and isotope-dilution liquid chromatography-tandem mass spectrometry. Anal Chem. 2011 Jun 15; 83(12):4729-37.
    View in: PubMed
    Score: 0.022
  26. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009 Jul 31; 58(RR-8):1-52.
    View in: PubMed
    Score: 0.020
  27. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009 Jul 10; 325(5937):197-201.
    View in: PubMed
    Score: 0.020
  28. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007 Jul 13; 56(RR-6):1-54.
    View in: PubMed
    Score: 0.017
  29. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis. 2006 Oct 15; 194(8):1032-9.
    View in: PubMed
    Score: 0.016
  30. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci U S A. 2006 Aug 08; 103(32):12121-6.
    View in: PubMed
    Score: 0.016
  31. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA. 2006 Feb 22; 295(8):891-4.
    View in: PubMed
    Score: 0.016
  32. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med. 2005 Dec 15; 353(24):2559-67.
    View in: PubMed
    Score: 0.015
  33. Human trials with wild-type H1N1 and recombinant H3N2-H1N1 influenza A viruses of 1977-1978. Infect Immun. 1980 Jun; 28(3):753-61.
    View in: PubMed
    Score: 0.010
  34. Comparative studies of wild-type and 'cold-mutant' (temperature sensitive) influenza viruses: geneology of the matrix (M) and non-structural (NS) proteins in recombinant cold-adapted H3N2 viruses. J Gen Virol. 1977 Oct; 37(1):145-59.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.